Antibodies which bind specifically to activin receptor like kinases
US7592428B1 · kind B1 · utility
6Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 2003 |
| Grant date | Sep 22, 2009 |
| Priority date | — |
| Expiry date | Feb 4, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A new receptor family has been identified, of activin-like kinases. Novel proteins have activin/TGF-β-type I receptor functionality, and have consequential diagnostic/therapeutic utility. They may have a serine/threonine kinase domain, a DFKSRN or DLKSKN sequence in subdomain VIB and/or a GTKRYM sequence in subdomain VIII.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.